Home » VELCURA THERAPEUTICS(R), INC. AND NIPPON CHEMIPHAR, CO., LTD. ANNOUNCE AGREEMENT TO DEVELOP NEW DRUG
VELCURA THERAPEUTICS(R), INC. AND NIPPON CHEMIPHAR, CO., LTD. ANNOUNCE AGREEMENT TO DEVELOP NEW DRUG
U.S. biotechnology company Velcura Therapeutics®, Inc. announced a license agreement with Nippon Chemiphar Co. (Chemiphar), Ltd., a Japanese pharmaceutical company listed on the Tokyo Stock Exchange. The license agreement enables the two companies to further develop new small-molecule therapies for osteoporosis and other bone diseases. This is a critical unmet need, as osteoporosis is second only to cardiovascular disease as a world health problem, according to the World Health Organization.
Yahoo News (http://biz.yahoo.com/prnews/050809/detu007.html?.v=21)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
07May
-
14May
-
30May